test

Hongbo Bao

@Decheng Capital Llc

Latest period2024 - Q3ReportedManaged Assets$422.193MTotal holdings26
Assets growth rate29.39%Assets growth rate (2-Q avg)-13.42%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Decheng Capital Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Decheng Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 422.193M in assets, with a quarterly growth rate of 29.39% and a 2-quarter average growth rate of -13.42%. The portfolio is managed by Hongbo Bao, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CGONCg Oncology Inc
Recent Activity
Increased 0.37%
48.97%
$206.716M
5.479M shares@ $37.73 avg price
NUVBNuvation Bio Inc.
Recent Activity
Increased 273.44%
14.08%
$59.436M
25.954M shares@ $2.29 avg price
PHATPhathom Pharmaceuticals Inc
Recent Activity
Increased 47.06%
5.36%
$22.6M
1.25M shares@ $18.08 avg price
KRYSKrystal Biotech Inc
Recent Activity
Increased 9.13%
3.1%
$13.065M
71,772 shares@ $182.03 avg price
ZNTLZentalis Pharmaceuticals Inc.
Recent Activity
Increased 1.23%
2.71%
$11.438M
3.108M shares@ $3.68 avg price
NAMSNewamsterdam Pharma Co Nv
Recent Activity
Increased 47.5%
2.32%
$9.794M
590,000 shares@ $16.6 avg price
MRUSMerus Nv
Recent Activity
Increased 5.59%
2.24%
$9.447M
189,098 shares@ $49.96 avg price
LEGNLegend Biotech Corp-adr
Recent Activity
Increased 10.15%
1.26%
$5.29M
108,558 shares@ $48.73 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 14.38%
1.02%
$4.301M
397,835 shares@ $10.81 avg price
ACLXArcellx Inc
Recent Activity
Increased 1699.24%
0.42%
$1.768M
21,177 shares@ $83.51 avg price